Figure 4.
High-risk myeloma defined by expression of three genes.
Cumulative incidence of event-free survival defined by the various combinations of expression of three genes. Note that only high RAN/low ZHX-2/low CHC1L shows dismal prognosis. It is important to note that the three-gene combination accounts for 66% of patient outcome variability. The best current models are near 30%.